Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to equity ratio high or low?
The debt to equity ratio of 0.01 is 45% below its 1-year average of 0.01, near the low end of its 1-year range (0.01–0.02).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly debt to equity ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.01.
DEBT TO EQUITY RATIO
0.01
DEBT TO EQUITY RATIO AVG TTM
N/A
DEBT TO EQUITY RATIO AVG 3Y
N/A
DEBT TO EQUITY RATIO AVG 5Y
N/A
DEBT TO EQUITY RATIO AVG 10Y
N/A
DEBT TO EQUITY RATIO AVG 15Y
N/A
DEBT TO EQUITY RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.11
median of 773 covered companies
CURRENT VS SECTOR MEDIAN
-92.87%
vs the sector median at left
Atrium Therapeutics, Inc.
Market Cap
$136.67M
Debt to Equity Ratio
0.01
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$136.57M
Debt to Equity Ratio
0.04
TTM Avg
0.02
3Y Avg
0.02
5Y Avg
0.02
Market Cap
$137.80M
Debt to Equity Ratio
0.18
TTM Avg
0.22
3Y Avg
0.21
5Y Avg
0.14
Market Cap
$139.04M
Debt to Equity Ratio
0.02
TTM Avg
0.06
3Y Avg
0.05
5Y Avg
0.05
Market Cap
$139.47M
Debt to Equity Ratio
0.00
TTM Avg
0.01
3Y Avg
0.01
5Y Avg
50.25
Market Cap
$139.84M
Debt to Equity Ratio
N/A
TTM Avg
0.37
3Y Avg
0.30
5Y Avg
0.23
Market Cap
$131.21M
Debt to Equity Ratio
0.67
TTM Avg
1.14
3Y Avg
1.25
5Y Avg
1.10
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | $136.67M | 0.01 | N/A | N/A | N/A |
| Organigram Global Inc. (OGI)vs › | $136.57M | 0.04 | 0.02 | 0.02 | 0.02 |
| KORU Medical Systems, Inc. (KRMD)vs › | $137.80M | 0.18 | 0.22 | 0.21 | 0.14 |
| Immuneering Corporation (IMRX)vs › | $139.04M | 0.02 | 0.06 | 0.05 | 0.05 |
| Alpha Cognition Inc (ACOG)vs › | $139.47M | 0.00 | 0.01 | 0.01 | 50.25 |
| Sutro Biopharma, Inc. (STRO)vs › | $139.84M | N/A | 0.37 | 0.30 | 0.23 |
| Freenome, Inc. (FRNM)vs › | $133.45M | N/A | N/A | N/A | N/A |
| LifeMD, Inc. (LFMD)vs › | $132.03M | 0.76 | 0.27 | 2.83 | 1.63 |
| AirSculpt Technologies, Inc. (AIRS)vs › | $131.21M | 0.67 | 1.14 | 1.25 | 1.10 |
| Health Catalyst, Inc. (HCAT)vs › | $130.79M | 1.69 | 0.90 | 0.77 | 0.69 |
Debt/Equity
0.01
Current Ratio
8.73
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2026-06-30 | 0.01 |
| 2026-03-31 | 0.01 |
| 2025-12-31 | 0.02 |
| 2025-09-30 | 0.02 |
